Roche, Ranbaxy Patent Fight Can Go To Trial

Law360, New York (July 11, 2008, 12:00 AM EDT) -- A federal judge has denied summary judgment motions and ruled that a patent suit brought by Roche Palo Alto LLC against generic rival Ranbaxy Laboratories Ltd. over a patent related to Roche's antiviral drug Valcyte can go to trial.

Judge Freda L. Wolfson, of the U.S. District Court for the District of New Jersey, ruled Wednesday that genuine issues of material fact remain concerning whether or not Ranbaxy has infringed the first six counts of Roche's patent.

Roche moved for summary judgment of infringement and Ranbaxy...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.